Recently, many studies [8–10] evaluated the potential of MMP-9 as a biomarker for the prognosis of various cancers, including cervical [11, 12], ovarian [13, 14], pancreatic [15], and breast cancers [16]. This evidence concerns the gene MMP9 and cancer.